The Latest Breaking News from Rite Aid

Rite Aid Corp (NYSE: RAD) shares closed Wednesday's regular session up more than 11% following a report suggesting the company rejected an $815 million takeover bid earlier this month.

Leading pharmaceutical retailer Rite Aid (RAD) shares jumped last week thanks to its stronger-than-expected fourth-quarter revenue growth driven by an increase in same-store and pharmacy sales. Although the company’s strategic initiatives to boost membership should bode well for the stock, its struggling Elixir business and expanding losses could lead to…

Rite Aid (NYSE:RAD) will host a conference call at 08:30 AM ET on April 14, 2022, to discuss Q4 2022 earnings results. How to Attend Rite Aid (RAD) Conference Call Follow this link to access the live webcast.

Analysts and brokerage firms often use ratings when they issue stock recommendations to stock traders. Analysts arrive at stock ratings by researching public financial statements, communicating with executives and customers, and following industry trends.

It is a rarity when Wall Street analysts come out with a “sell” rating on a company. Yet in this market environment, when it occurs, it has a notable impact on the company being targeted.

Upgrades

Ahead of the Company's fiscal Q4 results on April 14, Deutsche Bank downgraded Rite Aid Corporation (NYSE:RAD) to Sell from Hold with a price target of $1, down from $16. Analyst George Hill believes COVID has "hastened the decline" for the Company, and he sees the potential for a "dramatic negative inflection point"…

Rite Aid Corp (NYSE: RAD) shares are trading significantly lower Thursday after Deutsche Bank analyst George Hill downgraded the stock from a Hold rating to a Sell rating and lowered the price target from $16 to $1.

‘I can’t believe I’m seeing this s***,’ actor Michael Rapaport said